Drugs / BCG-Pasteur
BCG-Pasteur
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00427570 | Sep 1977 → May 2006 | colorectal cancer | NSABP Foundation Inc | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG-Pasteur | “5-Fluorouracil, 5-FU, NSC-19893; Methyl-CCNU, MeCCNU, NSC-95441; Vincristine, VCR, NSC-67574. Arm III: Immunotherapy. BCG-Pasteur, BCG, NSC-B116328.” NCT00427570 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00427570 ↗ |
| Known as | NSC-B116328 | “5-Fluorouracil, 5-FU, NSC-19893; Methyl-CCNU, MeCCNU, NSC-95441; Vincristine, VCR, NSC-67574. Arm III: Immunotherapy. BCG-Pasteur, BCG, NSC-B116328.” NCT00427570 ↗ |
| Modality | Vaccine | “BCG vaccine” NCT00427570 ↗ |